Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD?
No abstract is available. To read the body of this article, please view the Full Text online.
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Address correspondence to Jeffrey S. Berns, MD, University of Pennsylvania School of Medicine, Renal-Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, 3400 Spruce St, 1 Founders Pavilion, Philadelphia, PA 19104
